• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝星状细胞通过调节组蛋白乳酰化促进肝细胞癌的发展:单细胞 RNA 测序和空间转录组学分析的新见解。

Hepatic stellate cells promote hepatocellular carcinoma development by regulating histone lactylation: Novel insights from single-cell RNA sequencing and spatial transcriptomics analyses.

机构信息

Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, 110004, China.

Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, 110004, China.

出版信息

Cancer Lett. 2024 Nov 1;604:217243. doi: 10.1016/j.canlet.2024.217243. Epub 2024 Sep 10.

DOI:10.1016/j.canlet.2024.217243
PMID:39260669
Abstract

This study evaluated the cellular heterogeneity and molecular mechanisms of hepatocellular carcinoma (HCC). Single cell RNA sequencing (scRNA-seq), transcriptomic data, histone lactylation-related genes were collected from public databases. Cell-cell interaction, trajectory, pathway, and spatial transcriptome analyses were executed. Differential expression and survival analyses were conducted. Western blot, Real-time reverse transcription PCR (qRT-PCR), and Cell Counting Kit 8 (CCK8) assay were used to detect the expression of αSMA, AKR1B10 and its target genes, and verify the roles of AKR1B10 in HCC cells. Hepatic stellate cell (HSC) subgroups strongly interacted with tumor cell subgroups, and their spatial distribution was heterogeneous. Two candidate prognostic genes (AKR1B10 and RMRP) were obtained. LONP1, NPIPB3, and ZSWIM6 were determined as AKR1B10 targets. Besides, the expression levels of AKR1B10 and αSMA were significantly increased in LX-2 + HepG2 and LX-2 + HuH7 groups compared to those in LX-2 group, respectively. sh-AKR1B10 significantly inhibited the HCC cell proliferation and change the expression of AKR1B10 target genes, Bcl-2, Bax, Pan Kla, and H3K18la at protein levels. Our findings unveil the pivotal role of HSCs in HCC pathogenesis through regulating histone lactylation.

摘要

这项研究评估了肝细胞癌 (HCC) 的细胞异质性和分子机制。从公共数据库中收集了单细胞 RNA 测序 (scRNA-seq)、转录组数据和组蛋白乳酰化相关基因。进行了细胞-细胞相互作用、轨迹、通路和空间转录组分析。进行了差异表达和生存分析。使用 Western blot、实时逆转录 PCR (qRT-PCR) 和细胞计数试剂盒 8 (CCK8) 测定来检测αSMA、AKR1B10 及其靶基因的表达,并验证 AKR1B10 在 HCC 细胞中的作用。肝星状细胞 (HSC) 亚群与肿瘤细胞亚群强烈相互作用,其空间分布具有异质性。获得了两个候选预后基因 (AKR1B10 和 RMRP)。LONP1、NPIPB3 和 ZSWIM6 被确定为 AKR1B10 的靶基因。此外,与 LX-2 组相比,LX-2+HepG2 和 LX-2+HuH7 组中 AKR1B10 和αSMA 的表达水平显著增加。sh-AKR1B10 显著抑制 HCC 细胞增殖,并改变 AKR1B10 靶基因、Bcl-2、Bax、Pan Kla 和 H3K18la 的蛋白表达水平。我们的研究结果揭示了 HSCs 通过调节组蛋白乳酰化在 HCC 发病机制中的关键作用。

相似文献

1
Hepatic stellate cells promote hepatocellular carcinoma development by regulating histone lactylation: Novel insights from single-cell RNA sequencing and spatial transcriptomics analyses.肝星状细胞通过调节组蛋白乳酰化促进肝细胞癌的发展:单细胞 RNA 测序和空间转录组学分析的新见解。
Cancer Lett. 2024 Nov 1;604:217243. doi: 10.1016/j.canlet.2024.217243. Epub 2024 Sep 10.
2
A Novel lncRNA lncRNA-4045 Promotes the Progression of Hepatocellular Carcinoma by Affecting the Expression of AKR1B10.一种新型长链非编码RNA lncRNA - 4045通过影响AKR1B10的表达促进肝细胞癌进展。
Dig Dis Sci. 2024 Jul;69(7):2502-2521. doi: 10.1007/s10620-024-08383-z. Epub 2024 Apr 25.
3
AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment.AKR1B10 在肝细胞癌中的表达特征及其与临床病理特征和免疫微环境的关系。
Sci Rep. 2024 May 27;14(1):12149. doi: 10.1038/s41598-024-62323-5.
4
[Aldo-keto reductase family 1 B10 participates in the regulation of hepatoma cell cycle through p27/p-Rb signaling pathway].醛酮还原酶家族1B10通过p27/p-Rb信号通路参与肝癌细胞周期的调控
Zhonghua Gan Zang Bing Za Zhi. 2020 Oct 20;28(10):861-867. doi: 10.3760/cma.j.cn501113-20191113-00418.
5
Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production.肝细胞癌中的肝星状细胞通过生长分化因子 15 的产生促进肿瘤生长。
Gastroenterology. 2021 Apr;160(5):1741-1754.e16. doi: 10.1053/j.gastro.2020.12.015. Epub 2020 Dec 17.
6
CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression.CTGF 介导肝癌细胞与肝星状细胞之间的肿瘤-基质相互作用,加速 HCC 进展。
Cancer Res. 2018 Sep 1;78(17):4902-4914. doi: 10.1158/0008-5472.CAN-17-3844. Epub 2018 Jul 2.
7
Cluster of differentiation 147 is a key molecule during hepatocellular carcinoma cell-hepatic stellate cell cross-talk in the rat liver.分化簇147是大鼠肝脏中肝癌细胞与肝星状细胞相互作用过程中的关键分子。
Mol Med Rep. 2015 Jul;12(1):111-8. doi: 10.3892/mmr.2015.3429. Epub 2015 Mar 4.
8
Spatial transcriptomics reveals tumor-derived SPP1 induces fibroblast chemotaxis and activation in the hepatocellular carcinoma microenvironment.空间转录组学揭示肿瘤来源的 SPP1 诱导肝癌微环境中的成纤维细胞趋化和激活。
J Transl Med. 2024 Sep 12;22(1):840. doi: 10.1186/s12967-024-05613-w.
9
Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.肝癌中星状细胞的重构通过 CCN3 旁分泌调控基质衍生的奥沙利铂耐药性。
BMC Cancer. 2019 Dec 5;19(1):1192. doi: 10.1186/s12885-019-6362-1.
10
Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells.禁食可抑制肝星状细胞活化,并增强索拉非尼在肝癌细胞中的抗癌活性。
J Cell Physiol. 2018 Feb;233(2):1202-1212. doi: 10.1002/jcp.25987. Epub 2017 Jul 11.

引用本文的文献

1
Advances in Tumor Microenvironment and Immunotherapeutic Strategies for Hepatocellular Carcinoma.肝细胞癌的肿瘤微环境与免疫治疗策略进展
Oncol Res. 2025 Aug 28;33(9):2309-2329. doi: 10.32604/or.2025.063719. eCollection 2025.
2
Integrated analysis of single cell and spatial transcriptomics revealed a metastasis mechanism mediated by fatty acid metabolism in lymph nodes of head and neck cancer.单细胞和空间转录组学的综合分析揭示了头颈癌淋巴结中由脂肪酸代谢介导的转移机制。
Front Immunol. 2025 Aug 13;16:1614498. doi: 10.3389/fimmu.2025.1614498. eCollection 2025.
3
Crosstalk between lactylation and RNA modifications in tumorigenesis: mechanisms and therapeutic implications.
肿瘤发生过程中乳酸化与RNA修饰之间的相互作用:机制及治疗意义
Biomark Res. 2025 Aug 26;13(1):110. doi: 10.1186/s40364-025-00824-9.
4
Exploring the pathogenesis of acute lung injury and its treatment through Traditional Chinese Medicine: a state-of-the-art review.探索急性肺损伤的发病机制及其中医药治疗:一项最新综述。
Front Pharmacol. 2025 Jul 31;16:1592458. doi: 10.3389/fphar.2025.1592458. eCollection 2025.
5
Histone Lactylation in Diseases: Regulation by Traditional Chinese Medicine and Therapeutic Implications.疾病中的组蛋白乳酰化:中医药的调控作用及治疗意义
Drug Des Devel Ther. 2025 Jul 29;19:6435-6459. doi: 10.2147/DDDT.S524008. eCollection 2025.
6
The Emerging Role of Lactate and Lactylation Modifications in the Pathophysiology of Atherosclerotic Cardiovascular Diseases.乳酸和乳酸化修饰在动脉粥样硬化性心血管疾病病理生理学中的新作用
Cardiovasc Drugs Ther. 2025 Jul 7. doi: 10.1007/s10557-025-07732-y.
7
Protein lactylation and immunotherapy in gliomas: A novel regulatory axis in tumor metabolism (Review).胶质瘤中的蛋白质乳酰化与免疫治疗:肿瘤代谢中的一种新型调控轴(综述)
Int J Oncol. 2025 Jul;67(1). doi: 10.3892/ijo.2025.5764. Epub 2025 Jun 20.
8
Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy.肝细胞癌中的免疫微环境:从发病机制到免疫治疗
Cell Mol Immunol. 2025 Jun 11. doi: 10.1038/s41423-025-01308-4.
9
Lactylation modification in cancer: mechanisms, functions, and therapeutic strategies.癌症中的乳酸化修饰:机制、功能及治疗策略。
Exp Hematol Oncol. 2025 Mar 8;14(1):32. doi: 10.1186/s40164-025-00622-x.
10
Post-translational modifications in hepatocellular carcinoma: unlocking new frontiers in immunotherapy.肝细胞癌中的翻译后修饰:开启免疫治疗的新前沿
Front Immunol. 2025 Feb 18;16:1554372. doi: 10.3389/fimmu.2025.1554372. eCollection 2025.